SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950129-04-000314
Filing Date
2004-01-28
Accepted
2004-01-28 16:47:24
Documents
2
Group Members
ESSEX WOODLANDS HEALTH VENTURES FUND IV L L CESSEX WOODLANDS HEALTH VENTURES FUND IV L PIMMANUEL THANGARAJJAMES L CURRIEMATRIN P SUTTER

Document Format Files

Seq Description Document Type Size
1 ESSEX WOODLANDS HEALTH VENTURES FUND IV L.P. h12204sc13d.txt SC 13D 30182
3 JOINT FILING AGREEMENT h12204exv99wa.txt EX-99.A 2426
  Complete submission text file 0000950129-04-000314.txt   34854
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48459 | Film No.: 04549713
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10001 WOODLOCH FOREST DR STE 175 WOODLOCH TX 77380
Business Address 190 S LASALLE ST STE 2800 CHICAGO IL 60603
ESSEX WOODLANDS HEALTH VENTURES FUND IV L P (Filed by) CIK: 0001110080 (see all company filings)

IRS No.: 760573201 | State of Incorp.: DE | Fiscal Year End: 1231